Erectile drug ads push blunt sex appeal in race for market
The Levitra campaign uses a sultry, direct voiceover to tout erection quality and partner desire, signaling a bold shift in erectile dysfunction advertising. Analysts note Levitra’s aggressive style aims to compete with Viagra and Cialis, with market shares shifting as campaigns evolve and free trial programs expand.
MENTIONED IN THIS ARTICLE
New York
Levitra
Tising
Bob Dole
Pfizer Inc
Cialis
David Moskowitz
Friedman
Billings
Ramsey
Pfizer
Eli Lilly & Co
Icos Corp
David Pernock
GlaxoSmithKline
Glaxo
Bayer Pharmaceuticals Inc
Impact Rx
Levitra’s
Fewer embryos implanted in IVF lowers multiple births
A Boston study shows IVF practices reduced embryo transfer from an average of four to three per cycle from 1995 to 2001, with triplets or more dropping from 11 percent to 7 percent. Twins rates stayed steady. guidelines curb aggressive transfer amid evolving tech. Institutions urge careful use amid policy debates.
MENTIONED IN THIS ARTICLE
Boston
New England Journal of Medicine
Robert Rebar
American Society For Reproductive Medicine
Brigham and Women’s Hospital
Reducing Embryos in IVF Raises Birth Outcomes
The article notes that multiple pregnancies pose risks to both mothers and infants, with triplets common in older guidelines. It highlights voluntary limits of two to five embryos and describes how improved drugs, fertilization techniques, and culture methods have lowered embryo numbers while raising IVF success from 20 percent to 27 percent between 1995 and 2001.
Sleep problems in toddlers linked to teen substance use
A University of Michigan Health System study followed 257 boys for 10 years, finding poor sleep at ages 3 to 5 doubled the risk of substance abuse in adolescence. Authors note sleep issues may signal risk, not a fixed path, with data from mothers and teens. Girls data pending.
MENTIONED IN THIS ARTICLE
University of Michigan Health System
Maria Wong
Kirk Brower
Chelsea Arbor Treatment Center
University and Chelsea Community Hospital
Robert Zucker
Addiction Research Center
TLC Vision seeks rheopheresis cure for dry macular degeneration
TLC Vision Corp of Mississauga Ontario works on an experimental blood filtering treatment to prevent blindness from dry AMD. Rheopheresis uses a German invention with a Japanese filter to remove large proteins and fats, improving blood flow in the eye and possibly reversing vision loss. Analysts see growth potential if trials and regulatory hurdles clear for a mid 2005 launch, amid millions affected by dry AMD in the United States and rising baby boomer cases.
MENTIONED IN THIS ARTICLE
TLC Vision Corp
Mississauga
Ontario
Rhea
TLC
Elias Vamvakas
Vascular Sciences
U.S
Bausch & Lomb
Orion Securities
Aaron Bennett
Also Mentioned on This Page
New England Journal of Machone
Fetal Band Boosters
Alehs
Elyria High School
Pioneer Marching Band
NEWS
Ini
ST Nana
Mama
Onea
Toronto
Globe and Maui